TAT-C1aB

N/A

Report date: 2025/03/20 09:14:49

Base Information

Drug NameTAT-C1aB
Drug Alias Namepeptide targeting Kv2.1 channels (University of Pittsburgh)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPotassium voltage-gated channel subfamily B member 1 modulators
TargetsPotassium voltage-gated channel subfamily B member 1
Therapy Area/IndicationsIschemic StrokeNerve DegenerationAlzheimer Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pittsburgh
Inactive CompaniesN/A
Active IndicationsIschemic StrokeNerve DegenerationAlzheimer Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A